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Abstract
Two distinct classes of methicillin-resistant Staphylococcus aureus (MRSA) are spreading in hospitals (as hospital-acquired
MRSA, HA-MRSA) and in the community (as community-acquired MRSA, CA-MRSA). Multilocus sequence type (ST) 239
MRSA, one of the most worldwide-disseminated lineages, has been noted as a representative HA-MRSA. Here, we isolated
ST239 MRSA (spa type 3 [t037] and staphylococcal cassette chromosome mec [SCCmec] type III.1.1.1) and its novel variant
with ST239/spa351 (t030)/SCCmecIII.1.1.4 (SCCmecIIIR) not only from hospitals but also from patients with urethritis in the
community in Russia. The Russian variant (strain 16K) possessed a hybrid genome consisting of CC8 and CC30, similar to the
ST239/spa3/SCCmecIII.1.1.1 HA-MRSA (TW20) genome, but with marked diversity. The 16K9 CC30 section had SCCmecIIIR
carrying the dcs-carrying unit (which corresponded to the SCCmecIVc J3 joining region of ST30 CA-MRSA), lacked
SCCmercury, and possessed a novel mobile element structure (MES16K) carrying the ccrC-carrying unit (with the
recombinase gene ccrC1 allele 3) and drug resistance tranposons. The Russian variant included strains with a high ability to
transfer its multiple drug resistance by conjugation; e.g., for strain 16K, the transfer frequency of a chloramphenicol
resistance plasmid (p16K-1 with 2.9 kb in size) reached 1.4610
22, followed by Tn554 conjugative transfer at 3.66l0
24. The
Russian variant, which has been increasing recently, included divergent strains with different plasmid patterns and pulsed
field gel electrophoresis profiles. The data demonstrate the alternative nature of ST239 MRSA as CA-MRSA and also as a drug
resistance disseminator, and its micro but dynamic evolution in Russia.
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Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) was isolated in
the early 1960s and has continued to be a life-threatening multiple
drug-resistant bacterium in hospitals [1,2]. MRSA is generated
from methicillin-susceptible S. aureus (MSSA) by the acquisition of
staphylococcal cassette chromosome mec (SCCmec) at the 39 end of
orfX (SCCmec insertion site, att) [3]. It is considered that this has
occurred only a limited number of times, resulting in the current
epidemics in hospital settings [3–5].
Of these clones, ST239 MRSA is one of the most worldwide-
disseminated lineages [4,6], and is evolutionarily of interest,
because it is the first example of a bacterial hybrid, consisting of
two distinct MRSA belonging to clonal complex (CC) 30 (founder,
ST30) and CC8 (founder, ST8) [7,8]. The ST239 MRSA lineage
exhibits marked geographic variations [6] in terms of the protein A
gene (spa) type, SCCmec type III structures, and pulsed-field gel
electrophoresis (PFGE) patterns. Many terms have been used to
accommodate this variation [4], e.g., Brazilian clone [9],
Portuguese clone [10,11], Hungarian clone [12–14], Viennese
clone [15], and British EMRSA-1, -4, and -11 clones [16,17].
Of those, the Brazilian clone (first ST239 MRSA) spread among
hospitals in Brazil in 1992 [18], and then caused intercontinental
spread to hospitals in Portugal, possibly linked to Brazil-to-
Portugal migration of human populations since 1992–1993
[11,19]. The Hungarian clone emerged in hospitals in Hungary
in 1993, became predominant in hospitals until 1998, and then
almost disappeared in 2003–2004 from Hungary [12–14];
however, there is no single reference addressing the molecular
typing or characteristics of MRSA strains (Hungarian clone)
isolated in Hungary. SCCmec types were SCCmecIIIA for the
Brazilian clone (e.g., strain HU25) while SCCmecIII for the
Hungarian clone (e.g., strain HU106) [19].
Moreover, the ST239 TW clone (strain TW20) was noted as
intensive care unit (ICU)-associated MRSA in London between
2002 and 2004 [20], and the complete genome of TW20 was
described [8]. Harris et al. [6] have recently described the
comparative genomics of globally-collected ST239 strains using
Illumina genome analysis and the TW20 genome as a reference,
demonstrating the global geographic structure within ST239
MRSA, based on genome-wide single nucleotide polymorohisms
(SNPs). The ST239 lineage consisted of more than five MRSA
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e29187clades reflecting the continental origin, such as Asia, North
America, South America, Europe (with marked divergence), and
Australia, albeit with some intercontinental transmission cases.
According to the study of Harris et al. [6], TW20 clustered within
the Thai clade (most probably suggesting transmission from
southeast Asia to London), the Brazilian clone (e.g., strain HU25)
clustered within the South America clade, and Hungarian isolates
(during 1993–1996) exhibited divergent European phylogeny in
SNPs.
In the community, another class of MRSA, called community-
acquired MRSA (CA-MRSA), emerged during the period from
1997 to 1999 [2,21,22]. CA-MRSA includes clones belonging to
(e.g.) ST8 (USA300), ST30, and ST80 [2,22,23]. CA-MRSA
generally exhibits SCCmecIV or V, a narrow range of drug
resistance, and mecA-mediated low-level resistance to b-lactam
agents (oxacillin and imipenem) [1,2,22–24].
The term, hospital-acquired MRSA (HA-MRSA), which
includes MRSA isolated in the nosocomial environment, has been
used since the description of CA-MRSA. In this study, we isolated
MRSA, including ST239 MRSA, from patients in hospitals and
also from patients with nongonococcal urethritis in the community
in Russia, and examined the molecular characteristics of these
MRSA strains. We also investigated the comparative genomics of
an ST239 variant (strain 16K) with unique features in terms of
evolution and drug resistance using the TW20 genome as a
reference.
Materials and Methods
Patients and bacterial strains
Thirteen outpatients were enrolled in this study, all of whom
were male outpatients (age range, 19–40 years; mean age, 29
years) of two hospitals in Vladivostok, Russia, through the period
from 2006 to 2008. All outpatients had discharge (pus) from the
urethra, discomfort inside the urethra, and discomfort while
passing urine. Examination of swabs (discharge) from the urethra
revealed the presence of polymorphonuclear neutrophils and
MRSA in all cases; no other pathogens, such as Neisseria gonorrhea,
Chlamydia, Ureaplasma, Mycoplasma, Candia, Trichomonas and STD-
associated viruses, were detected; therefore, outpatients were
diagnosed with nongonococcal urethritis due to MRSA. No
nosocomial or familial transmissions were observed. The 13
MRSA (including strain 16K) were epidemiologically diagnosed as
CA-MRSA; in this study, CA-MRSA was defined as MRSA
isolated from outpatients who had no history of hospitalization
within at least the past year and presented with no other
established risk factors for MRSA infections, such as surgery,
residence in a long-term care facility, dialysis, or indwelling
percutaneous medical devices and catheters; and HA-MRSA was
defined as MRSA isolated from inpatients 48 h after hospitaliza-
tion [2,22].
In this study, 18 HA-MRSA strains, isolated from inpatients
(age, 34–71 years; mean age, 51.8 years) in four hospitals in
Vladivostok between 2004 and 2008, were also examined; they
were isolated from surgical wound infections, pneumonia, and
blood stream infection (including sepsis). Five HA-MRSA strains
were isolated from inpatients (age, 3–64 years; mean age, 26.6
years) in two hospitals in Vladivostok in 2011 from surgical wound
infections and burn infections. This study was complied with the
ethics review board Niigata University School of Medicine,
Niigata, Japan. Written informed consent was obtained from
patients.
The epidemic HA-MRSA-type strains included ANS46 (refer-
ence strain isolated in 1982 in Australia; ST239/SCCmecIII),
HU25 (Brazilian clone; ST239/SCCmecIIIA), BK2464 (New
York/Japan clone; ST5/SCCmecII), BM18 (Pediatric clone;
ST5/SCCmecIVa), HDE288 (Pediatric clone; ST5/SCCmecVI),
HAR22 (EMRSA-15 clone; ST22/SCCmecIV), HAR24
(EMRSA-16 clone; ST36/SCCmecII), HAR38 (Berlin clone;
ST45/SCCmecIVa), HPV107 (Iberian clone; ST247/SCCmecIA),
and COL (Archaic clone; ST250/SCCmecI); they were kindly
provided by H. de Lencastre. CA-MRSA strain NN1 (ST30/
SCCmecIVc), which was positive for the collagen adhesin gene
(cna), was isolated from a child with bullous impetigo in the
community [25,26].
Genotyping and virulence gene analysis
MRSA typing was performed as described previously [27]. The
spa type was analyzed by PCR using reference strains, and
determined using public spa type databases, eGenomics (http://
tools.egenomics.com/) or Ridom SpaServer (http://spaserver.
ridom.de/). Typing of agr was carried out by PCR with previously
reported primers [28,29] or by sequencing the variable region
[30]. SCCmec types (I to V) were analyzed by PCR using reference
strains [31,32]. The subtypes of SCCmecIII were described
expressing the differences in the J1, J2, and J3 joining regions,
according to the guidelines described in 2009 [33]. For virulence
gene analysis, the target genes included 46 genes; 3 leukocidin
genes (lukPVSF, lukE-lukD, and lukM), 5 hemolysin genes (hla, hlb,
hlg, hlg-v, and hld), 18 staphylococcal enterotoxin (SE) genes (tst, sea,
seb, sec, sed, see, seg, seh, sei, sej, sek, sel, sem, sen, seo, sep, seq, and ser), 1
putative staphylococcal enterotoxin gene (seu), 3 exfoliative toxin
genes (eta, etb, and etd), an exotoxin-like gene cluster (set), the
epidermal cell differentiation inhibitor gene (edin), and 14 adhesin
genes (icaA, icaD, eno, fib, fnbA, fnbB, ebpS, clfA, clfB, sdrC, sdrD, sdrE,
cna, and bbp) [27].
PFGE analysis
Bacterial DNA was digested with SmaI and the digested DNA
was applied to PFGE (1.2% agarose), as described previously [34].
A lambda ladder (Bio-Rad Laboratories, Tokyo, Japan) was used
as the molecular size standard.
Plasmid analysis
Plasmid DNA of MRSA strains was prepared using a Plasmid
Midi Kit (QIAGEN Sciences, Tokyo). Plasmid DNA was
introduced into MRSA by electroporation using a Gene Pulser
II electroporator (Bio-Rad).
Conjugative transfer
Donor strains were mated with S. aureus RN2677 (recipient
strain, which is restriction-negative and resistant to rifampicin and
novobiocin) on membrane filters on tryptic soy agar (Difco,
Sparks, MD, USA) (filter mating), as previously described [25];
RN2677 was used as a recipient because it carried no plasmids and
had non-transmissible drug resistance (recipient) markers. In some
experiments, donor and recipient cultures were mixed at 1:2,
centrifuged, and spotted on tryptic soy agar without filters (non-
filter mating). Alternatively, donor and recipient cultures were
mixed in tryptic soy broth (Difco) (liquid mating). The resistance
genes of donor strains and transconjugants were examined by
PCR as previously described [27].
Susceptibility testing
Bacterial susceptibility testing was carried out according to
previous procedures [35]. Breakpoints for drug resistance were
those described by the CLSI [35].
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The MRSA 16K genome was analyzed by pyrosequencing
using a genome sequencer FLX system with the assembler
software GS De Novo Assembler version 2.0 (Roche Diagnostics,
Branford, CT, USA); pyrosequencing analysis yields contigs of
larger sizes than Illumina genome analysis. In this study, 274,241
reads yielded 111 Mb raw sequences, corresponding to approx-
imately 37-fold of the genome size; GenBank accession numbers
for the 16K genome (107 contigs with $20 bp in size) are
BABZ01000001-BABZ01000107. Constructed contigs were
mapped on the 3,043,210-bp complete TW20 genome [GenBank
accession number FN433596; 6] using MUMmer software
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Figure 1. PFGE patterns of MRSA isolated from outpatients
with nongonococcal urethritis and from inpatients in Russia
compared with ST239 reference strains. MRSA groups (A1–A4, B1–
B3, and C1 and C2) are described in Table 1. The Russian variant of
ST239 MRSA (groups A2, B2, and C2) is marked with shading (yellow).
Strains 6K to 51K (n=13) are isolated from outpatients during 2006–
2008: (group A1) 6K, 8K, 14K, 22K, 39K, 47K; (group A2) 16K, 20K, 49K,
51K; (group A3) 12K and 40K; (group A4) 23K. Strains 1H to 18H (n=18)
are isolates from inpatients during 2004–2008: (group B1) 1H, 2H, 8H,
9H, 11H, 12H, 13H, 15H, 16H, 17H, 18H; (group B2) 3H, 4H, 5H, 6H, 7H,
14H; (group B3) 10H. Strains 101H to 105H (n=5) are isolates from
inpatients in 2011: (group C1) 101H; (group C2) 102H, 103H, 104H,
105H.
doi:10.1371/journal.pone.0029187.g001
Genome and Resistance of Russian ST239 MRSA
PLoS ONE | www.plosone.org 4 January 2012 | Volume 7 | Issue 1 | e29187(http://mummer.sourceforge.net/). The gene or open reading
frame (orf) was searched for using the software in silico
MolecularCloning (version 4.2) (In Silico Biology, Yokohama,
Japan).
Phylogenetic and homology analysis
Phylogenetic tree analysis was performed using TreeViewX
software (version 0.5.0) (http://taxonomy.zoology.gla.ac.uk/rod/
treeview.html). The bootstrap value (1000) represents the accuracy
of a branch in the phylogenetic tree (analysis was repeated 1,000
times). Homology analysis was performed using the software
BLAST (http://blast.ddbj.nig.ac.jp/top-e.html) and FASTA
(http://fasta.ddbj.nig.ac.jp/top-j.html).
Results
Characteristics of MRSA from outpatients with urethritis
in the community
Data are summarized in Table 1 and Figure 1. Thirteen MRSA
strains were classified into four groups (A1 to A4) (Table 1). Group
A1 (n=6) exhibited ST239/spa3/SCCmecIII.1.1.1 and shared the
same genotype with ST239 reference strains, TW20 and ANS46,
Figure 2. Genome information for ST239 MRSA strain 16K in comparison with ST239 MRSA strain TW20. The genome information
includes drug resistance genetic traits (related structures and mutations), virulence genes, superantigen-associated phages, and plasmids. The 16K
genome contigs, obtained by pyrosequencing, were mapped on the 3,043,210-bp TW20 genome (GenBank accession number FN433596; shown as a
circle). The information on the 16K and TW20 genomes is presented outside and inside the genome circle, respectively. Colored regions in the 16K
genome map: green, highly homologous to TW20; yellow, non- or less homologous to TW20; blue, slightly divergent from TW20; brown, insertion.
Drug resistance (r): Oxa, oxacillin; Tet, tetracycline; Min, minocycline; Rif, rifampicin; Lvx, levofloxacin; Chl, chloramphenicol; Ery, erythromycin; Spt,
spectinomycin; Gen, gentamicin; Kan, kanamycin; Amp, ampicillin; Ery, erythromycin. MDR, multiple drug resistance. The three plasmids of strain 16K
are shown at the right bottom of the figure. The CC30 and CC8 genome sections are from Holden et al. [8].
doi:10.1371/journal.pone.0029187.g002
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PLoS ONE | www.plosone.org 5 January 2012 | Volume 7 | Issue 1 | e29187Figure 3. The SCCmecIIIR structure of ST239 MRSA strain 16K. GenBank accession number for SCCmecIIIR is AB539727. The data for strain
TW20 are from GenBank accession number FN433596. Homologous regions are shaded. In A, when the structure of SCCmecIIIR was compared with
SCCmercury/SCCmecIII.1.1.1 of TW20 (upper part of figure), the SCCmecIII core was shared by the two, but the left side regions (flanked by att and
IS431) of SCCmecIIIR and SCCmecIII.1.1.1 showed no homology. Moreover, Strain 16K lacked SCCmercury. The dcs-carrying unit (marked in pink) was
shared by SCCmecIIIR, SCCmecIV, SCCmecII, and SCCmecI (lower part of figure). The data for strains JCSC6668, NN1, 80s-2, CA05, N315, and
NCTC10442 were from GenBank accession numbers AB425823, AB245470, AB245471, AB063172, NC_002745, and AB033763, respectively. In B, the
mosaic SCCmecIIIR structure was specifically detected by multiplex PCR. Multiplex PCR detects targets: P1 and P2 in the SCCmecIII core, P3 in the left
side region (attM-pT181) of SCCmecIII.1.1.1, P4 in the left side region (dcs-carrying unit) of SCCmecIIIR, and PM1 (in an orf) and PM2 in SCCmercury or
MES16K (PCR targets are shown in this figure [in A] and Fig. 4 for SCCmercury, and in Fig. 4 for MES16K); strain 16K was negative for the mer operon
(lacked SCCmercury). ST239/SCCmecIII.1.1.1 MRSA strain ANS46 gave five PCR bands; three bands (P1, P2, and P3) for SCCmecIII.1.1.1 and two bands
(PM1 and PM2) for SCCmercury. In contrast, the Russian variant (strain 16K) gave different combinations of five PCR bands; three bands (P1, P2, and
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PLoS ONE | www.plosone.org 6 January 2012 | Volume 7 | Issue 1 | e29187but was distinct from HU25. Group A1 strains shared the same
PFGE pattern (Figure 1).
Group A2 (n=4) was a variant of the ST239 lineage. These
strains (including 16K) exhibited spa351/SCCmecIII.1.1.4 (named
SCCmecIIIR), were resistant to chloramphenicol and rifampicin
and susceptible to trimethoprim, and possessed a 2.9-kb
chloramphenicol-resistance plasmid (Table 1). Group A2 strains
shared the same PFGE pattern, except for one strain (49K)
(Figure 1); 49K exhibited a divergent agr subtype (named agr1’; see
Fig. S1 for detailed analysis) and plasmid profile (Table 1).
Group A3 (n=2; ST8/SCCmecIVc) and group A4 (n=1;
ST72/SCCmecIVc) exhibited a narrow range of drug resistance
and low oxacillin and imipenem resistance levels (Table 1),
similarly to CA-MRSA [24].
The ST239 lineage strains, but not ST8 or ST72 strains, were
positive for the collagen adhesin gene (cna). Of the epidemic-type
HA-MRSA clones, EMRSA-15 (ST22), EMRSA-16 (ST36), and
Berlin (ST45) were also cna-positive.
Characteristics of MRSA from inpatients
Data are summarized in Table 1 and Figure 1. Of 18 MRSA
strains epidemiologically diagnosed as HA-MRSA during 2006–
2008, 11 strains belonged to group B1 (ST239/spa3/SCCme-
cIII.1.1.1) and corresponded to group A1; one strain (strain 2H)
possessed a 41-kb chloramphenicol-resistance plasmid. Six strains
belonged to group B2 (ST239/spa351/SCCmecIIIR) and corre-
sponded to group A2, although most B2 strains possessed a 41-kb
chloramphenicol-resistance plasmid. The remaining strain be-
longed to group B3 (ST8/SCCmecIVc) and resembled group A3.
Therefore, around 2006, the ST239/spa3/SCCmecIII.1.1.1 type
was the most prevalent and the variant (ST239/spa351/SCCme-
cIIIR) type was the second most prevalent, not only in the
community but also in hospitals.
Of the five MRSA strains epidemiologically diagnosed as HA-
MRSA in 2011, one strain (group C1) corresponded to group A1
or B1. Four strains (group C2) exhibited the same genotype as
group A2 or B2, indicating the increase of the ST239 variant type
in 2011; however, of four C2 strains, three strains exhibited slightly
distinct PFGE profiles and plasmid patterns (containing 2.9-kb
chloramphenicol resistance and 38-kb cadmium resistance plas-
mids) (Table 1 and Figure 1).
Comparative genomics of the ST239 Russian variant
(strain 16K)
The 16K genome sequence was compared with the TW20
genome (Figure 2). The 16K genome was estimated to be at least
2.8 Mb in size, showing approximately 99.9% homology with the
TW20 region (in green), excluding four large non- or less
homologous regions (283.6-Kb, in yellow). The CC30 and CC8
hybrid regions on the genome were assigned according to Holden
et al. [8].
In the CC30 section, 16K possessed SCCmecIIIR instead of
SCCmecIII.1.1.1. Moreover, 16K lacked SCCmercury, but
possessed a novel mobile element structure (MES16K), which
carried the recombinase gene (ccrC)-carrying unit [36], similarly to
SCCmercury.
There were several phage deletions in16K: WSa1 and WSPb-like
wereabsent;andapartofWSa3waslacking(FigureS2A).Moreover,
marked divergence was observed with SaPI1 (Figure S2B).
In 16K, the blaz gene (encoding ampicillin resistance) was
located in ICE6013 (Figure 2), and the tetM gene (encoding
tetracycline and minocycline resistance) was in a smaller Tn5801-
like structure, which lacked dfrG (encoding trimethoprim resis-
tance) (Figure S2C). Rifampicin resistance (MIC, 256 mg/ml) was
due to Leu 466Ser and His481Asn mutations in rpoB, and
levofloxacin resistance (MIC, 4 mg/ml) was due to mutations
Ser80Phe in grlA and Glu88Lys in gyrA (Figure 2).
Strain 16K possessed three plasmids, 2.9-kb chloramphenicol
resistance plasmid (p16K-1), 3.0-Kb putative exported protein
plasmid (p16K-2), which corresponded to 3.0-Kb pTW20_2 of
TW20, and 2.3-Kb multidrug resistance efflux protein plasmid
(p16K-3), which showed similarity to 2.4-Kb pPSK108 of S.
epidermidis.
SCCmecIIIR structure of strain 16K
The complete sequence of 16K SCCmecIIIR was determined
(Figure 3A). It was 31,198 bp in size, and consisted of 15-bp attL
(adjacent to orfX), 2,208-bp dcs-carrying unit (J3 region), 28,960-bp
SCCmecIII core region (carrying mecA complex and ccr complex),
and 15-bp attR. The J3 region of 16K showed no homology with
the 6,266-bp J3 region of TW20. The dcs-carrying unit (J3) was
shared by 16K SCCmecIIIR, SCCmecI, SCCmecII, and SCCmecIV
(Figure 3A); of those, the sequences of 16K SCCmecIIIR and
SCCmecIVc (of ST30 CA-MRSA strains NN1 and 80s-2) were
identical, suggesting that the dcs-carrying unit (J3) of 16K
SCCmecIIIR was acquired by recombination. The mosaic
SCCmecIIIR structure was identified by multiplex PCR
(Figure 3B), although PCR (PM1 and PM2) detected MES16K
in strain 16K (which lacked SCCmercury).
MES16K structure of strain 16K
The complete sequence of MES16K was determined
(Figure 4A). It was 30,818 bp in size and flanked by 16-bp
inverted repeats (IRs). MES16K was inserted into the orf on the
16K genome, corresponding to SATW20_27600 of TW20; the att
(target) sequence was 8-bp long, and was duplicated at both ends
of MES16K. The 8-bp att and 16-bp IR sequences showed no
homology to the 15-bp att sequences for SCCmecIII or SCCmer-
cury. MES16K shared a similar ccrC-carrying unit with SCCmer-
cury, albeit with ccrC1 allele 3 for 16K and ccrC1 novel allele 10 for
TW20 (Figure 4B) and also with IS insertion in ccrC1 in TW20 (but
not in 16K). Tn554 was present in both MES16K and
SCCmercury, but in MES16K, Tn4001 was inserted into the
ermA gene of Tn554.
Conjugative transfer of drug resistance
The ST239/spa351/SCCmecIIIR variant (especially group A2)
transferred its drug resistance to S. aureus RN2677 by bacterial
mating on agar plates, in the order of chloramphenicol,
erythromycin, gentamicin, cadmium, and tetracycline resistance
(Table 2).
Plasmids were detected only in chloramphenicol-resistant
transconjugants (Tables 1 and 2). For group A2 MRSA (isolated
from the community during 2006–2008), the size of chloram-
phenicol-resistance plasmids was 2.9-kb. The sequence of the
chloramphenicol-resistance plasmid (GenBank accession number,
AB539725), donated from strain 16K (group A2), was consistent
with p16K-1 in Figure 2. In contrast, for MRSA strains from
P4) for SCCmecIIIR and two bands (PM1 and PM2, marked with arrows) for MES16K. PCR band P4 was shared by SCCmecIIIR and SCCmecIVc (and
SCCmecIVa, SCCmecII, and SCCmecI). The combination of P1, P2, P4, PM1, and PM2 was unique to the Russian variant (strain 16K).
doi:10.1371/journal.pone.0029187.g003
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PLoS ONE | www.plosone.org 7 January 2012 | Volume 7 | Issue 1 | e29187Figure 4. MES16K structure and phylogenetic tree analysis for the ccrC genes. The SCCmercury data for strain TW20 are from GenBank
accession number FN433596. The GenBank accession number of MES16K is AB666466. Homologous regions are shaded. In A, for strain TW20, the
ccrC-carrying unit was located within SCCmercury; the ccrC gene (marked in yellow) was split by the insertion of IS (IS200 family). For strain 16K, the
ccrC-carrying unit was located within a mobile element structure MES16K, which was inserted into the orf (corresponding to SATW20_27600 of TW20)
on the 16K genome, as shown in Fig. 2; the ccrC gene (marked in yellow) was intact. The attachment sequence (att) of MES16K showed no homology
to that (att) of the orfX, SCCmecIII.1.1.1 or SCCmercury. Arrowheads PM1 and PM2 represent PCR targets for detection of SCCmercury of ST239/
SCCmecIII.1.1.1 MRSA and MES16K of the Russian variant (strain 16K) by multiplex PCR (Fig. 3). In B, the ccrC gene sequence of strain 16K and that of
strain TW20 (expected intact ccrC gene sequence, obtained by excluding the inserted IS200-family sequence) were analyzed for phylogenetic
diversity, as described previously [36]. The ccrC gene of strain TW20 was a novel ccrC1 allele (named ccrC1 allele 10) and that of strain 16K was
assigned as ccrC1 allele 3, unambiguously demonstrating evolutionary diversity between them; moreover, the ccrC1 gene of ST398 MRSA strain S0385
was also a novel allele (named ccrC1 allele 11).
doi:10.1371/journal.pone.0029187.g004
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strains), the plasmid size was 41-kb or 30-kb. And, for MRSA from
hospitals in 2011, the plasmid size in one strain (strain 105H) was
41-kb, while the plasmid size in three strains (strains 102H, 103H,
and 104H) was 2.9-kb, indicating periodical changes of chloram-
phenicol-resistance plasmids.
No transfer or low-level transfer was observed for ST239/spa3/
SCCmecIII.1.1.1 strains (groups A1, B1, and C1), except for strain
2H (group B1) which donated a 41-kb chlorampenicol resistance
plasmid (Table 2). Moreover, group A1 strain 6K carrying p16K-1,
which was constructed by introduction of p16K-1 DNA into strain
6K by electroporation, gave no transconjugants, indicating that
p16K-1 transfer occurred in a host (strain 16K)-dependent manner.
In mating between 16K and RN2677, erythromycin-resistant
transconjugants (including RN2677-16KEmA2) possessed Tn554
(GenBank accession number, AB539726) inserted into the radC
gene (Figures 2 and 5A). There were no repeats at either terminus
of Tn554 and no repeats of the ‘‘target’’ sequence, unlike other
transposons (as reported previously [37–39]). The hexanucleo-
tide sequence at the left end of Tn554 in RN2677-16KEmA2
Table 2. Conjugative transfer of drug resistance from Russian MRSA strains to S. aureus RN2677.
Donor MRSA strains
a Strains examined (n) Transfer frequency
b: drug-resistant recipients/donor
(recipient, RN2677)
Chloramphenicol
resistance
Erythromycin
resistance
Gentamicin
resistance
Tetracycline
resistance
Oxacillin
resistance
Cadmium
resistance
Russian isolates
Group A1 6 –
c ,1.0610
29 ,1.0610
29 ,1.0610
29 ,1.0610
29 ,1.0610
29
(ST239/spa3)
Group A2 4 1.4610
22 –3 . 6 610
24 –1 . 0 610
25 –2 . 8 610
28 – ,1.0610
29 2.1610
26 –
(ST239/spa351) 5.3610
24d 6.7610
25 6.9610
26 5.6610
29 1.8610
27
(cat/p2.9) (ermA)( aacA-aphD)( tetM)( cadA)
Group A3 2 9.5610
25 –1 . 8 610
25 ,1.0610
29 –
c ,1.0610
29 ,1.0610
29
(ST8/spa826) 3.0610
26 (ermA)
(cat/p2.9)
Group A4 1 –
c –
c –
c –
c ,1.0610
29 ,1.0610
29
(ST72/spa3451)
Group B1
(ST239/spa3) 10 –
c ,1.0610
29 ,1.0610
29 ,1.0610
29 ,1.0610
29 ,1.0610
29
(ST239/spa3) 1
e 2.3610
23 ,1.0610
29 ,1.0610
29 ,1.0610
29 ,1.0610
29 ,1.0610
29
(2/p41)
Group B2 6 1.1610
22 –4 . 2 610
27 –3 . 7 610
28 – ,1.0610
29 ,1.0610
29 ,1.0610
29
(ST239/spa351) 9.7610
23 1.6610
28 1.6610
28
(2/p41 or p30) (ermA)( aacA-aphD)
Group C1 1 –
c ,1.0610
29 ,1.0610
29 ,1.0610
29 ,1.0610
29 ,1.0610
29
(ST239/spa3)
Group C2
(ST239/spa351) 1
f 6.5610
23 5.5610
24 5.7610
25 ,1.0610
29 ,1.0610
29 3.9610
27
(2/p41) (ermA)
(ST239/spa351) 3
g 3.3610
26 –5 . 2 610
27 – ,1.0610
29 ,1.0610
29 ,1.0610
29 6.4610
27 –
1.2610
27 2.0610
27 1.5610
27
(cat/p2.9) (ermA)( cadA,cadD/
p38)
ST239 reference strains
ANS46 ,1.0610
29 9.5610
28 –
c ,1.0610
29 ,1.0610
29 ,1.0610
29
(ermA)
HU25 –
c 6.0610
26 ,1.0610
29 ,1.0610
29 ,1.0610
29 ,1.0610
29
(ermA)
aGroups of MRSA strains from Russia are from Table 1.
bDrug resistance genes acquired by transconjugants are shown in parentheses (cat, chloramphenicol resistance; ermA, erythromycin and clindamycin resistance; aacA-
aphD, gentamicin and kanamycin resistance; tetM, tetracycline and minocycline resistance; cadA, cadmium resistance; 2, no previously-described sequences). Plasmid
size was described after the resistance gene in parentheses.
cDonor MRSA strains were susceptible to each drug (resulting in no transconjugants).
dResistance transfer frequencies (average data in two or three experiments) for four group2 isolates were 1.4610
22, 6.5610
23,1 . 0 610
23, and 5.3610
24.
e, f, gStrain 2H; 105H; and 102H, 103H, and 104H, respectively.
doi:10.1371/journal.pone.0029187.t002
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PLoS ONE | www.plosone.org 9 January 2012 | Volume 7 | Issue 1 | e29187Figure 5. The structure of Tn554 and its circular intermediate in erythromycin-resistant transconjugants (RN2677-16KEmA2).
Transconjugant RN2677-16KEmA2 was obtained by mating between strain 16K (donor) and S. aureus RN2677 (recipient). The data for strain TW20 are
from GenBank accession number FN433596. In A, Tn554 was integrated into the radC gene in RN2677, at exactly the same site as the Tn554
integration site in radC for strain TW20; the radC right-side hexanucleotide sequence, immediately adjacent to Tn554, is marked in blue. The Tn554
left-side hexanucleotide sequence (marked in red) was distinct between the two Tn554 sequences of strains RN2677-16KEmA2 and TW20, reflecting
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PLoS ONE | www.plosone.org 10 January 2012 | Volume 7 | Issue 1 | e29187(59-GACATC) was distinct from that of Tn554 within the TW20
radC gene (59-CAAGCT) (Figure 5A; sequence in red), reflecting
the former target site sequence [37–39] in each case. The free
circular intermediate of Tn554 was present for both donor strain
16K and transconjugant RN2677-16KEmA2 (Figure 5B–D). For
Tn554 in the transconjugant, there was a deletion in spc
(Figure 5A), although it still conferred spectinomycin resistance.
Conjugative transfer of erythromycin resistance was also
observed for group A3, group B2, group C2, and ST239 reference
strains ANS46 and HU25 (Table 2); these transconjugants also
carried spectinomycin resistance gene (spc) and were positive for a
Tn554 circular intermediate by PCR (data not shown).
Discussion
The ST239 MRSA lineage is a representative multiple drug-
resistant HA-MRSA circulating worldwide [2,4–6,8]; for example,
it includes TW20, which emerged in an ICU in London [20].
Harris et al. [6] recently demonstrated, based on genome-wide
SNPs, that the ST239 lineage consisted of more than five MRSA
clades, such as Asia, North America, South America, Europe, and
Australia. In this study, we isolated two divergent ST239 MRSA
groups with spa3/SCCmecIII.1.1.1 and spa351/SCCmecIIIR from
Russia; the latter has tended to increase recently. According to
Harris et al. [6], spa3 (t037) represents the ancestral (most
prevalent) ST239 spa type, and the spa3 type is distributed
worldwide, including North and South America, Australia,
Europe, and Asia. In contrast, the spa351 (t030) type has been
found only in areas of Europe. Based on this, together with the
deletion patterns of genomic islands and mobile genetic elements
by Harris et al. [6], the Russian ST239/spa351/SCCmecIIIR
variant may belong to the European clade, suggesting possible
transmission from Europe to Far Eastern Russia (although
SCCmecIII subtypes or sequences have not been described by
Harris et al. [6]).
The two ST239 MRSA groups in Russia were isolated not
only from patients in hospitals but also from patients with
nongonococcal urethritis in the community; therefore, MRSA
may be an agent of sexually transmitted disease in Russia, which
would cause great concern about the potential to spread in the
community. When the Russian ST239 MRSA strains (spa3/
SCCmecIII.1.1.1 or spa351/SCCmecIIIR) from hospitals and the
community were compared, there was a marked divergence in
plasmid patterns; e.g., a 2.9-kb chloramphenicol-resistance
plasmid in group A2 vs. a 41-kb chloramphenicol-resistance
plasmid in group B2. Moreover, the ST239/spa351/SCCmecIIIR
variant isolated recently (in 2011) showed a slightly divergent
PFGE pattern, suggesting micro but dynamic evolution in
Russia.
The CC30 genome section of the ST239 hybrid genome (16K)
carried two mobile elements, SCCmecIIIR and MES16K, and
three potential virulence genes, spa [40,41], cna [26,42], and psm-
mec (encoding a peptide cytolysin [43]). SCCmecIIIR was a mosaic
SCCmec, consisting of the SCCmecIII core and dcs-carrying unit (as
a J3 region). An identical dcs-carrying unit was found in
SCCmecIVc of ST30 CA-MRSA (strains NN1 and 80s-2 in Japan
[25,44] and also strain RS08 in Russia [45]), indicating that the
dcs-carrying unit of the Russian variant could originate in ST30
CA-MRSA. The dcs-carrying unit corresponds to a region with the
ccrC-carrying unit in SCCmecVII [36] (now renamed SCCmecV
[33]). This region flanked by orfX(attL) and IS431 seems to be a hot
spot for recombination.
In strain 16K, the ccrC-carrying unit, found in SCCmecV and
SCCmercury [36], was located in MES16K, which carried a
composite transposon. MES16K is markedly distinguished from
SCCmer or SCCmercury, even in terms of the attachment
sequence (att). The ccrC gene is highly variable; for example, it is
ccrC1 allele 3 for strain 16K, ccrC1 allele 8 for ST59 CA-MRSA
strain PM1 [36], and ccrC1 allele 10 (novel allele type) for ST239
HA-MRSA strain TW20.
One of the most striking features of the Russian variant is its
behavior as a multiple drug resistance disseminator. To our
knowledge, this is the first demonstration of multiple drug
resistance transfer in the ST239 MRSA lineage. For mating,
close contact of donor and recipient cells on agar plates is
needed, but the use of filters is not essential. There is a possibility
that during close-contact mating, plasmids in donor (16K) cells
are preferably transferred into recipient bacterial cells, as in the
case of p16K-1. For Tn554, which transposes through the
circular intermediate [38,39], the circular intermediate may be
transferred, followed by subsequent integration into the recipient
genome, thus exhibiting lower transfer frequency than a
chloramphenicol plasmid (p16K-1).
In conclusion, the ST239/spa3/SCCmecIII.1.1.1 MRSA and its
variant (ST239/spa351/SCCmecIIIR) have emerged not only in
hospitals but also in the community, associated with nongonococ-
cal urethritis, in Russia. The Russian variant showed high
similarity to TW20 in terms of the bulk of the hybrid genome,
but was markedly divergent from TW20, such as spa351 vs. spa3,
novel mosaic SCCmecIIIR vs. SCCmecIII.1.1.1, MES16K vs.
SCCmercury, and the presence vs. absence of small chloram-
phenicol-resistance plasmids. The Russian variant behaved as a
drug resistance disseminator, mediating chloramphenicol-resis-
tance plasmid transfer and conjugative Tn554 transposition.
Micro but dynamic evolution of ST239 MRSA is proceeding in
Russia.
Supporting Information
Figure S1 The agr subtyping for the Russian variant strain 49K.
In A, PCR primers for agr typing are shown as an arrow. Strains:
agr1, agr1 type strain; agr2, agr2 type strain; 49K, the Russian
variant strain 49K. Strain 49K produced a product only for
primer sets (Pan and agr1), and not for (Pan and agr2), assigning
strain 49K as agr1. However, in the other PCR assay, strain 49K
produced a product both for primer sets (agr1 forward and agr1
reverse) and for agr2 forward and agr2 reverse, resulting in no
precise assignment. In B, the agr subtypes were examined by
phylogenetic tree analysis, based on the nucleotide sequences of
the agr variable region, as described previously [30]. GenBank
previous target site sequences for each Tn554 (note that the orientation of the Tn554 structure in the figure is opposite, when compared with
previously described Tn554 structures [37–39]). The spc gene on Tn554 in a transconjugant (RN2677-16KEmA2) had a single base substitution,
resulting in a truncated gene product (lacking 27-aa at the 39-end); the mutated spc gene still conferred spectinomycin resistance. In B, since Tn554
transposes through a circular intermediate [38–39], PCR primers to detect a Tn554 circular intermediate were designed for Tn554 originated in strain
16K. In C, the PCR primer set (CI/F and CI/R, shown in B) exactly detected a Tn554 circular intermediate in strains 16K and RN2677-16KEmA2 (PCR
product size, 772 bp) in PCR assay; there were no such bands for strain RN2677. In D, when the sequence of the PCR product, obtained in C, was
determined, the Tn554 circular intermediate in RN2677-16KEmA2 possessed the radC hexanucleotide (59-TACATC; marked in blue), but not the Tn554
hexanucleotide sequence (59-GACATC; marked in red).
doi:10.1371/journal.pone.0029187.g005
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AB592345. Based on the data, strain 49K was assigned as agr19.
(TIF)
Figure S2 Deletions in drug resistance or virulence genetic traits
in 16K, in comparison with TW20. The data of strain TW20 are
from GenBank accession number FN433596. Homologous regions
are shaded. In A, contigs 41, 14, 85, and 63 (and probably 77) of
strain 16K constituted the bulk of the WSa3 phage sequence,
showing the presence of the sea gene (encoding superantigen SEA,
a virulence factor associated with severe invasive infections) in
strain 16K; no right side sequence of WSa3 was present. In B,
contigs 4 and 13 of strain 16K constituted the left and right side
regions of the SaPI1 superantigen-associated pathogenicity island,
showing the presence of the superantigen genes sek and seq in strain
16K. In C, contigs of 42 and 28 of strain 16K constituted the
Tn5801-like sequence (including 20-bp direct repeat at both ends),
but with deletion of the dfrG gene sequence (encoding trimetho-
prim resistance) in contig 28. Strain 16 was also negative for dfrG
by PCR assay.
(TIF)
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